Literature DB >> 787816

Scintigraphic skeletal changes in uremic patients on regular hemodialysis.

K Olgaard, J Heerfordt, S Madsen.   

Abstract

99Tcm-polyphosphate (Tc-PP) bone scintigraphy was performed in 30 consecutive uremic patients on regular hemodialysis and compared with a normal control group. 27 of the patients (90%) had pathological accumulation on the scintigrams, while roentgenographic abnormalities were present in only 10 patients (33%), indicating that scintigraphy is superior to X-ray in the early detection of skeletal changes in uremic patients. In the group with the most pronounced uptake on the scintigrams there was a preponderance of previously kidney-transplanted patients, while no correlation could be demonstrated between the severity of the scintigraphic findings and the duration of the hemodialysis period, the anephric state of the patients, the underlying kidney disease or the sex. It is suggested that intensive glucocorticoid treatment, even of short duration in the previously kidney-transplanted patients, may aggravate uremic osteodystrophy.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 787816     DOI: 10.1159/000180738

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  9 in total

1.  Observations on computerized quantitative bone scintigraphy in renal osteodystrophy.

Authors:  P de Graaf; E K Pauwels; P H Vos; I M Schicht; J te Velde; J de Graeff
Journal:  Eur J Nucl Med       Date:  1984

2.  Increased bone radiotracer uptake in renal osteodystrophy. Clinical evidence of hyperparathyroidism as the major cause.

Authors:  P de Graaf; J te Velde; E K Pauwels; I M Schicht; K Kleiverda; J de Graeff
Journal:  Eur J Nucl Med       Date:  1982

3.  Noninvasive measurements of bone mass and their clinical significance.

Authors:  S H Cohn; J F Aloia; J M Letteri
Journal:  Calcif Tissue Res       Date:  1978-11-10

4.  Generalized soft tissue calcification in children and adolescents with end stage renal failure.

Authors:  R van Diemen-Steenvoorde; R A Donckerwolcke; G de Haas
Journal:  Eur J Pediatr       Date:  1986-09       Impact factor: 3.183

5.  Semi-quantitative interpretation of the bone scan in metabolic bone disease: definition and validation of the metabolic index.

Authors:  I Fogelman; D L Citrin; J G Turner; I D Hay; R G Bessent; I T Boyle
Journal:  Eur J Nucl Med       Date:  1979-08-01

6.  Bone scintigraphy and densitometry in symptomatic haemodialysis bone disease.

Authors:  C Alberts; J B van der Schoot; E Busemann-Sokole
Journal:  Eur J Nucl Med       Date:  1981

Review 7.  Scintigraphy in the clinical evaluation of disorders of mineral and skeletal metabolism in renal failure.

Authors:  F A de Jonge; E K Pauwels; N A Hamdy
Journal:  Eur J Nucl Med       Date:  1991

8.  Deconvolution analysis of 99mTc-methylene diphosphonate kinetics in metabolic bone disease.

Authors:  J Knop; E Kröger; P Stritzke; C Schneider; H P Kruse
Journal:  Eur J Nucl Med       Date:  1981-02

9.  Treatment of renal osteodystrophy with 1,25-dihydroxycholecalciferol.

Authors:  C Velentzas; D G Oreopoulos; A Pierratos; H E Meema; S Rabinovich; H Meindok; H Husdan; T M Murray; R Ogilvie; A Katirtzoglou
Journal:  Can Med Assoc J       Date:  1981-03-01       Impact factor: 8.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.